JP2003512434A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003512434A5 JP2003512434A5 JP2001532793A JP2001532793A JP2003512434A5 JP 2003512434 A5 JP2003512434 A5 JP 2003512434A5 JP 2001532793 A JP2001532793 A JP 2001532793A JP 2001532793 A JP2001532793 A JP 2001532793A JP 2003512434 A5 JP2003512434 A5 JP 2003512434A5
- Authority
- JP
- Japan
- Prior art keywords
- renal failure
- chronic renal
- patient
- dialysis
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19951471A DE19951471A1 (de) | 1999-10-26 | 1999-10-26 | Verwendung von Urodilatin zur Behandlung chronischer Niereninsuffizienz mit Nierenrestfunktionen |
| DE19951471.2 | 1999-10-26 | ||
| PCT/EP2000/010462 WO2001030376A2 (de) | 1999-10-26 | 2000-10-24 | Verwendung von urodilatin zur behandlung chronischer niereninsuffizienz mit nierenrestfunktionen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003512434A JP2003512434A (ja) | 2003-04-02 |
| JP2003512434A5 true JP2003512434A5 (enExample) | 2008-11-13 |
Family
ID=7926884
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001532793A Pending JP2003512434A (ja) | 1999-10-26 | 2000-10-24 | 残された腎機能を有する慢性腎不全を治療するためのウロジラチンの使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6831064B1 (enExample) |
| EP (1) | EP1223968B1 (enExample) |
| JP (1) | JP2003512434A (enExample) |
| AT (1) | ATE239497T1 (enExample) |
| DE (2) | DE19951471A1 (enExample) |
| ES (1) | ES2198359T3 (enExample) |
| WO (1) | WO2001030376A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2392892T3 (es) | 2005-04-07 | 2012-12-14 | Cardiopep Pharma Gmbh | Uso de un péptido natriurético para tratar insuficiencia cardiaca |
| US20080181903A1 (en) * | 2006-12-21 | 2008-07-31 | Pdl Biopharma, Inc. | Conjugate of natriuretic peptide and antibody constant region |
| ES2575397T3 (es) * | 2007-09-11 | 2016-06-28 | Cardiopep Pharma Gmbh | Uso de péptidos natriuréticos para el tratamiento de síndromes de angioedema |
| EP2078530A1 (en) | 2008-01-08 | 2009-07-15 | Pharis Biotec GmbH | Use of natriuretic peptides for treating angioedema syndromes |
| WO2010033240A2 (en) | 2008-09-19 | 2010-03-25 | Nektar Therapeutics | Carbohydrate-based drug delivery polymers and conjugates thereof |
| EP2948165A2 (en) | 2013-01-25 | 2015-12-02 | Cardiorentis Ltd. | A natriuretic peptide, a diuretic peptide or a vasodilatory peptide for use in methods of treating cardiovascular indications |
| WO2022029499A1 (en) | 2020-08-06 | 2022-02-10 | Ads Aiphia Development Services Ag | Methods of treating refractory ascites |
| WO2022029497A1 (en) | 2020-08-06 | 2022-02-10 | Ads Aiphia Development Services Ag | Ularitide for use in methods of treating refractory ascites |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2819467B2 (ja) * | 1987-03-02 | 1998-10-30 | ファーマ・ビッセンドルフ・ペプタイド・ゲーエムベーハー | 新規なカルジオジラチン断片およびその製造方法 |
| US5691310A (en) | 1987-09-29 | 1997-11-25 | Vesely; David L. | Methods of treatment using proANF peptides |
| DE4216133A1 (de) * | 1992-05-15 | 1993-11-18 | Bissendorf Peptide Gmbh | Anwendung von Urodilatin bei Lungen- und Bronchialerkrankungen |
| US5741776A (en) * | 1995-05-22 | 1998-04-21 | Genentech, Inc. | Method of administration of IGF-I |
| US5565428A (en) * | 1995-05-22 | 1996-10-15 | Genentech, Inc. | Method of administration of IGF-I |
| PL191377B1 (pl) * | 1996-12-31 | 2006-05-31 | Ajay Gupta | Kompozycje farmaceutyczne do hemodializy i dializy otrzewnowej oraz sposób hemodializy i dializy otrzewnowej |
-
1999
- 1999-10-26 DE DE19951471A patent/DE19951471A1/de not_active Withdrawn
-
2000
- 2000-10-24 ES ES00975905T patent/ES2198359T3/es not_active Expired - Lifetime
- 2000-10-24 WO PCT/EP2000/010462 patent/WO2001030376A2/de not_active Ceased
- 2000-10-24 DE DE50002119T patent/DE50002119D1/de not_active Expired - Lifetime
- 2000-10-24 AT AT00975905T patent/ATE239497T1/de not_active IP Right Cessation
- 2000-10-24 JP JP2001532793A patent/JP2003512434A/ja active Pending
- 2000-10-24 US US10/088,498 patent/US6831064B1/en not_active Expired - Lifetime
- 2000-10-24 EP EP00975905A patent/EP1223968B1/de not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE334710T1 (de) | Kostengüstige infusionsvorrichtung | |
| AU7368896A (en) | Limited backflow reflux valve | |
| CA2312468A1 (en) | Catheter system of specified dead space for the delivery of a low volume liquid bolus | |
| BR9811825A (pt) | Uso de lactobacillus para redução do nìvel de fibrinogênio no sangue | |
| FR2806918B1 (fr) | Catheter pour l'administration specifique d'un medicament | |
| WO2001019334A3 (en) | Pharmaceutical solutions of levosimendan | |
| CA2544963A1 (en) | Myo-inositol hexaphosphate for topical use technical field | |
| WO2000064456A3 (en) | Substitution infusion fluid and citrate anticoagulation | |
| JP2003512434A5 (enExample) | ||
| NZ514911A (en) | Use of N-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients | |
| CA2396209A1 (en) | The use of mirtazapine for the treatment of sleep disorders | |
| Schwenk et al. | The pharmacokinetics of acetazolamide during CAPD | |
| ES2164630T3 (es) | Sistema combinado de varios aparatos medicos para anestesia total intravenosa. | |
| BR0316059A (pt) | Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise | |
| CA2238920A1 (en) | Nephroprotective pharmaceutical composition and use thereof | |
| Gray et al. | Chlormethiazole sedation for critically ill patients in renal failure | |
| KR20240008579A (ko) | 정맥주사 연결용 2방향 커넥터 | |
| 李麗琴 et al. | The Use of Diazepam, Midazolam and Propofol for Sedation in the Surgical Intensive-Care Unit | |
| Agraharkar | Multiple drugs Hypokalaemia and lack of efficacy | |
| KR900013956A (ko) | 디메르캅토숙신산(dmsa)으로 규소를 감소시키는 방법 | |
| Zhonghua et al. | The factors related to fungal peritonitis in patients on peritoneal dialysis | |
| RU97121508A (ru) | Способ оказания неотложной медицинской помощи при длительной компрессионной травме конечности | |
| Janicke | Factors affecting the pharmacokinetics of beta-lactam antibiotics. | |
| MXPA03002114A (es) | Uso de arginina en la preparacion de un medicamento para la prevencion y tratamiento de los efectos secundarios asociados con la administracion intravenosa de productos farmaceuticos. | |
| Lee | By the way, doctor. After a recent blood pressure check, my doctor bumped up my dose of Lotensin [an ACE inhibitor] from 10 milligrams to 20. I had been taking the 10-mg pill in the morning, but my doctor advised me to take the new, higher dose in the evening. He said most strokes and heart attacks happen in the morning, and that I could get better protection by taking the drug right before. But I read in the Health Letter a couple of months ago that you recommend morning intake, so I am confused |